摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-<4'-(Dimethylamino)-2'-butinyl>isoxazolidin-3-on | 116445-18-2

中文名称
——
中文别名
——
英文名称
2-<4'-(Dimethylamino)-2'-butinyl>isoxazolidin-3-on
英文别名
2-(4-Dimethylamino-but-2-ynyl)-isoxazolidin-3-one;2-[4-(dimethylamino)but-2-ynyl]-1,2-oxazolidin-3-one
2-<4'-(Dimethylamino)-2'-butinyl>isoxazolidin-3-on化学式
CAS
116445-18-2
化学式
C9H14N2O2
mdl
MFCD09031496
分子量
182.222
InChiKey
ZDZCQJUIQDQGSU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    113-116 °C
  • 沸点:
    260.6±50.0 °C(Predicted)
  • 密度:
    1.128±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.4
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.666
  • 拓扑面积:
    32.8
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-<4'-(Dimethylamino)-2'-butinyl>isoxazolidin-3-on 、 (6-bromohexyl)dimethyl-[3-(1,3-dioxo-1,3-dihydroisoindol-2-yl)propyl]ammonium bromide 以 乙腈 为溶剂, 生成
    参考文献:
    名称:
    Design, Synthesis, and Action of Oxotremorine-Related Hybrid-Type Allosteric Modulators of Muscarinic Acetylcholine Receptors
    摘要:
    A novel series of muscarinic receptor ligands of the hexamethonio-type was prepared which contained, on one side, the phthalimidopropane or 1,8-naphthalimido-2,2-dimethylpropane moiety typical for subtype selective allosteric antagonists and, on the other, the acetylenic fragment typical for the nonselective orthosteric muscarinic agonists oxotremorine, oxotremorine-M, and related muscarinic agonists. Binding experiments in M-2 receptors using [H-3]N-methylseopolamine as an orthosteric probe proved an allosteric action of both groups of hybrids, 7a-10a and 8b-10b. The difference in activity between a-group and b-group hybrids corresponded with the activity difference between the allosteric parent compounds. In M-1-M-3 muscarinic isolated organ preparations, most of the hybrids behaved as subtype selective antagonists. [S-35]GTP gamma S binding assays using human M-2 receptors overexpressed. in CHO cells revealed that a weak intrinsic efficacy was preserved in 8b-10b. Thus, attaching muscarinic allosteric antagonist moieties to orthosteric muscarinic agonists may lead to hybrid compounds in which functions of both components are mixed.
    DOI:
    10.1021/jm050769s
  • 作为产物:
    描述:
    二甲胺2-(4-chloro-2-butynyl)isoxazolidin-3-oneN,N-二甲基甲酰胺 为溶剂, 以65%的产率得到2-<4'-(Dimethylamino)-2'-butinyl>isoxazolidin-3-on
    参考文献:
    名称:
    新型与oxotremorine和oxotremorine-M有关的衍生物的合成和功能表征。
    摘要:
    合成并测试了与氧代雷莫林和氧代雷莫林-M有关的两个非季铵化(5a-10a)和季铵化衍生物(5b-10b)的亚系列。在三种经典的体外功能测定中,估计了新化合物毒蕈碱受体亚型的激动剂效力:M1兔输精管,M2豚鼠左心房和M3豚鼠回肠。另外,将中毒蕈毒碱作用的发生评估为小鼠腹膜内给药后的致发色活性。在体外测试中,所有衍生物均表现出非选择性毒蕈碱活性,在某些情况下其效力值超过了参考化合物(即8b)。仅对类氧代短发膜样衍生物9a证明了其功能选择性,该衍生物表现为混合的M3激动剂/ M1拮抗剂(pD2 = 5.85; pA2 = 4.76,分别)。在体内试验中,非季铵化合物能够引起中央毒蕈碱作用,其效力与体外观察到的效力顺序平行。
    DOI:
    10.1016/s0968-0896(99)00107-8
点击查看最新优质反应信息

文献信息

  • Synthesis and functional characterization of novel derivatives related to oxotremorine and oxotremorine-M
    作者:Clelia Dallanoce、Paola Conti、Marco De Amici、Carlo De Micheli、Elisabetta Barocelli、Milena Chiavarini、Vigilio Ballabeni、Simona Bertoni、Mariannina Impicciatore
    DOI:10.1016/s0968-0896(99)00107-8
    日期:1999.8
    Two subseries of nonquaternized (5a-10a) and quaternized derivatives (5b-10b) related to oxotremorine and oxotremorine-M were synthesized and tested. The agonist potency at the muscarinic receptor subtypes of the new compounds was estimated in three classical in vitro functional assays: M1 rabbit vas deferens, M2 guinea pig left atrium and M3 guinea pig ileum. In addition, the occurrence of central
    合成并测试了与氧代雷莫林和氧代雷莫林-M有关的两个非季铵化(5a-10a)和季铵化衍生物(5b-10b)的亚系列。在三种经典的体外功能测定中,估计了新化合物毒蕈碱受体亚型的激动剂效力:M1兔输精管,M2豚鼠左心房和M3豚鼠回肠。另外,将中毒蕈毒碱作用的发生评估为小鼠腹膜内给药后的致发色活性。在体外测试中,所有衍生物均表现出非选择性毒蕈碱活性,在某些情况下其效力值超过了参考化合物(即8b)。仅对类氧代短发膜样衍生物9a证明了其功能选择性,该衍生物表现为混合的M3激动剂/ M1拮抗剂(pD2 = 5.85; pA2 = 4.76,分别)。在体内试验中,非季铵化合物能够引起中央毒蕈碱作用,其效力与体外观察到的效力顺序平行。
  • Die Position 5 im Oxotremorin-Gerüst: Eine zentrale Stelle für die Steuerung der Aktivität am muscarinischen Rezeptor
    作者:René Amstutz、Annemarie Closse、Gernot Gmelin
    DOI:10.1002/hlca.19870700827
    日期:1987.12.16
    Position 5 at the Oxotremorine Skeleton as the Stearing Position for Activity at the Muscarinic Receptors
    Oxotremorine骨架上的位置5作为毒蕈碱受体活性的固定位置
  • AMSTUTZ, RENE;CLOSSE, ANNEMARIE;GMELIN, GERNOT, HELV. CHIM. ACTA, 70,(1987) N 8, 2232-2244
    作者:AMSTUTZ, RENE、CLOSSE, ANNEMARIE、GMELIN, GERNOT
    DOI:——
    日期:——
  • Design, Synthesis, and Action of Oxotremorine-Related Hybrid-Type Allosteric Modulators of Muscarinic Acetylcholine Receptors
    作者:Teresa Disingrini、Mathias Muth、Clelia Dallanoce、Elisabetta Barocelli、Simona Bertoni、Kerstin Kellershohn、Klaus Mohr、Marco De Amici、Ulrike Holzgrabe
    DOI:10.1021/jm050769s
    日期:2006.1.1
    A novel series of muscarinic receptor ligands of the hexamethonio-type was prepared which contained, on one side, the phthalimidopropane or 1,8-naphthalimido-2,2-dimethylpropane moiety typical for subtype selective allosteric antagonists and, on the other, the acetylenic fragment typical for the nonselective orthosteric muscarinic agonists oxotremorine, oxotremorine-M, and related muscarinic agonists. Binding experiments in M-2 receptors using [H-3]N-methylseopolamine as an orthosteric probe proved an allosteric action of both groups of hybrids, 7a-10a and 8b-10b. The difference in activity between a-group and b-group hybrids corresponded with the activity difference between the allosteric parent compounds. In M-1-M-3 muscarinic isolated organ preparations, most of the hybrids behaved as subtype selective antagonists. [S-35]GTP gamma S binding assays using human M-2 receptors overexpressed. in CHO cells revealed that a weak intrinsic efficacy was preserved in 8b-10b. Thus, attaching muscarinic allosteric antagonist moieties to orthosteric muscarinic agonists may lead to hybrid compounds in which functions of both components are mixed.
查看更多

同类化合物

(R)-4-异丙基-2-恶唑烷硫酮 麻黄恶碱 顺-八氢-2H-苯并咪唑-2-酮 顺-1-(4-氟苯基)-4-[1-(4-氟苯基)-4-羰基-1,3,8-三氮杂螺[4.5]癸-8-基]环己甲腈 非达司他 降冰片烯缩醛3-((1S,2S,4S)-双环[2.2.1]庚-5-烯-2-羰基)恶唑烷-2-酮 阿齐利特 阿那昔酮 阿洛双酮 阿帕鲁胺 阿帕他胺杂质2 铟烷-2-YL-甲基胺盐酸 钠2-{[4,5-二羟基-3-(羟基甲基)-2-氧代-1-咪唑烷基]甲氧基}乙烷磺酸酯 重氮烷基脲 詹氏催化剂 解草恶唑 解草噁唑 表告依春 螺莫司汀 螺立林 螺海因氮丙啶 螺[1-氮杂双环[2.2.2]辛烷-8,5'-咪唑烷]-2',4'-二酮 苯甲酸,4-氟-,2-[5,7-二(三氟甲基)-1,8-二氮杂萘-2-基]-2-甲基酰肼 苯氰二硫酸,1-氰基-1-甲基-4-氧代-4-(2-硫代-3-噻唑烷基)丁酯 苯妥英钠杂质8 苯妥英-D10 苯妥英 苯基硫代海因半胱氨酸钠盐 苯基硫代乙内酰脲-谷氨酸 苯基硫代乙内酰脲-蛋氨酸 苯基硫代乙内酰脲-苯丙氨酸 苯基硫代乙内酰脲-色氨酸 苯基硫代乙内酰脲-脯氨酸 苯基硫代乙内酰脲-缬氨酸 苯基硫代乙内酰脲-异亮氨酸 苯基硫代乙内酰脲-天冬氨酸 苯基硫代乙内酰脲-亮氨酸 苯基硫代乙内酰脲-丙氨酸 苯基硫代乙内酰脲-D-苏氨酸 苯基硫代乙内酰脲-(NΕ-苯基硫代氨基甲酰)-赖氨酸 苯基乙内酰脲-甘氨酸 苏氨酸-1-(苯基硫基)-2,4-咪唑烷二酮(1:1) 色氨酸标准品002 膦酸,(2-羰基-1-咪唑烷基)-,二(1-甲基乙基)酯 脱氢-1,3-二甲基尿囊素 聚(d(A-T)铯) 羟甲基-5,5-二甲基咪唑烷-2,4-二酮 羟基香豆素 美芬妥英 美芬妥英